Results

Total Results: 983 records

Showing results for "the consumer assessment of healthcare providers and systems".

981. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
     January 01, 2023 - The DEcIDE network assists health care providers, patients, and policymakers seeking unbiased information … adults and the risk of MI or SCD. … Because the computerized data systems at study sites had differing start-up dates, ranging from 1986 … Given the very low prevalence of use of ADHD medications in adults and the relatively low rates of the … However, with these surveillance systems, which are known to only capture a small percent of adverse

982. Insulin-Blood-Sugar-2010 Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
     January 01, 2010 - The object is to help consumers, health care providers, and others in making informed choices among … Continuous glucose monitoring (CGM) systems address these issues by recording blood glucose levels day … Data Extraction and Quality Assessment Data Abstraction We extracted information on general study characteristics … Quality Assessment We used different quality assessment tools for RCTs and observational studies. … The feasibility of creating a checklist for the assessment of the methodological quality both of randomised

983. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
     September 01, 2011 - The object is to help consumers, health care providers, and others in making informed choices among treatment … between the increased risk of death and antipsychotics drugs, and comparison of the development of adverse … , iloperidone, and paliperidone) have been approved by FDA for the treatment of schizophrenia and bipolar … for only a few of the drugs and for only a few of the off-label indications. … Most of the evidence is for the drugs risperidone, olanzapine, and quetiapine, for the off-label indications